Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 With Expansion Cohorts in a Study of NEO-201 in Adults With Chemo-Resistant Solid Tumors

NCT03476681 is registered in ClinicalTrials.gov with Precision Biologics, Inc as lead sponsor.

NCT NCT03476681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03476681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 With Expansion Cohorts in a Study of NEO-201 in Adults With Chemo-Resistant Solid Tumors
Lead sponsor
Precision Biologics, Inc
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
January 18, 2019
Completion date
November 30, 2026
Enrollment
121 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, head and neck squamous cell carcinoma, non small cell lung cancer, uterine cancer